Keyphrases
Novel Therapeutics
100%
Acute Myeloid Leukemia
100%
Murine Model
100%
Human Disease
100%
Bortezomib
50%
Knock-in Mouse Model
50%
MiR-29b
37%
Liposomal
25%
DNA Methyltransferase 1 (DNMT1)
25%
Leukemia Mice
25%
Dnmt
25%
Leukemia
12%
High Risk
12%
Bone Marrow
12%
Remission
12%
Apoptosis
12%
Poor Outcome
12%
Dose Effect
12%
Autopsy
12%
Co-expression
12%
Disease-free
12%
FLT3 Internal Tandem Duplication
12%
Global DNA Methylation
12%
Tandem Duplication
12%
Cytogenetically Normal Acute Myeloid Leukemia
12%
Duplication mutation
12%
Methylation Index
12%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Diseases
100%
Bortezomib
44%
microRNA 29b
33%
Ex Vivo
11%
Programmed Cell Death
11%
down Regulation
11%
DNA Methyltransferase
11%
DNA Methylation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Diseases
100%
Bortezomib
44%
microRNA 29b
33%
Remission
11%
DNA Methyltransferase
11%
Neuroscience
Myeloid
100%
Bortezomib
44%
microRNA 29b
33%
In Vivo
22%
DNA Methylation
11%
DNA Methyltransferase
11%
Programmed Cell Death
11%
Immunology and Microbiology
Myeloid
100%
down Regulation
11%
DNA Methylation
11%
Programmed Cell Death
11%